Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2002
03/20/2002EP1187830A1 Process for the preparation of paroxetine and structurally related compounds
03/20/2002EP1187829A1 Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
03/20/2002EP1187828A1 Quinoline derivatives as antibacterials
03/20/2002EP1187827A1 Antiviral agents
03/20/2002EP1187826A1 Heterocyclic derivatives useful as anticancer agents
03/20/2002EP1187821A1 Benzofuranylsulfonates
03/20/2002EP1187817A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
03/20/2002EP1187816A1 5-cyano-2-aminopyrimidine derivatives
03/20/2002EP1187815A1 4-phenyl-pyrimidine derivatives
03/20/2002EP1187814A2 5-phenyl-pyrimidine derivatives
03/20/2002EP1187813A1 Azolylbenzamides and analogues and their use for treating osteoporosis
03/20/2002EP1187812A2 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
03/20/2002EP1187811A1 Inhibitors of metalloproteinases
03/20/2002EP1187810A2 Heterocyclic analgesic compounds and their use
03/20/2002EP1187803A1 Amorphous nitric esters and their pharmaceutical compositions
03/20/2002EP1187637A2 Alpha or beta emitters attached to fragments in radioimmunotherapy
03/20/2002EP1187635A1 Anaesthetic formulation comprising an nmda-antagonist and an alpha-2 adrenergic agonist
03/20/2002EP1187632A1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES
03/20/2002EP1187629A2 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
03/20/2002EP1187628A2 Metabolic intervention with glp-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain
03/20/2002EP1187622A1 Method of sterilizing
03/20/2002EP1187620A1 Antisense modulation of b7 protein expression
03/20/2002EP1187619A1 Anti-tumor agents comprising boroproline compounds
03/20/2002EP1187618A1 Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use
03/20/2002EP1187617A2 Topical ophthalmic mast cell stabilizers for treating allergic eye diseases
03/20/2002EP1187616A1 Thrombin inhibitors
03/20/2002EP1187615A2 Immunosurpressive effects of pteridine derivatives
03/20/2002EP1187614A1 Substituted piperidines as melanocortin-4 receptor agonists
03/20/2002EP1187613A1 Amide substituted imidazoquinolines
03/20/2002EP1187612A1 Use of riluzole for the treatment of multiple sclerosis
03/20/2002EP1187611A2 Ophthalmic histamine compositions and uses thereof
03/20/2002EP1187610A2 Use of ion channel modulating agents
03/20/2002EP1187608A1 Indole compounds
03/20/2002EP1187607A1 Indole compounds
03/20/2002EP1187606A1 Pharmaceutical composition containing sibutramine and orlistat
03/20/2002EP1187605A1 Non-malignant disease treatment with ras antagonists
03/20/2002EP1187604A1 Compounds and methods for the treatment of post traumatic stress disorder
03/20/2002EP1187603A1 Combination therapy for effecting weight loss and treating obesity
03/20/2002EP1187601A1 Novel preparation and administration form comprising an acid-labile active compound
03/20/2002EP1187600A1 Method for enhancing stable cellular creatine concentration
03/20/2002EP1187599A1 Stable benzimidazole formulation
03/20/2002EP1187598A1 Micropigment mixture
03/20/2002EP1187592A2 Alpha v integrin receptor antagonists
03/20/2002EP1187531A1 Macrophage scavenger receptor antagonists
03/20/2002EP1156040A4 2,4-dioxo-5-arylidenimino-1,3-pyrimidines
03/20/2002EP1143796A4 Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method
03/20/2002EP1137415A4 Myt1 kinase inhibitors
03/20/2002EP1090029B1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for the production thereof and pharmaceutical preparations containing said compounds
03/20/2002EP1077687B1 Multiparticulate pharmaceutical form with programmed and timed release and preparation method
03/20/2002EP1064002B9 Use of sphingosin-1-phosphate, sphingosin-1-phosphate derivatives and/or mixtures thereof for the treatment of inflammatory diseases of the skin
03/20/2002EP1019050B1 Use of somatostatin agonists and antagonists for treating diseases related to the eye
03/20/2002EP1017696B1 Acidic addition salts of morphine alkaloids and the application thereof
03/20/2002EP1011674B1 Transdermal therapeutic system containing the active substance scopolamine base
03/20/2002EP1009396B1 Pharmaceutical formulation comprising a 2-aminoacetamide derivative and an ion exchange resin
03/20/2002EP0986568B1 Novel class of nucleic acid cationic transfecting agents
03/20/2002EP0960110B1 3-ARYL SUBSTITUTED PYRAZOLO 4,3-d]PYRIMIDINE DERIVATIVES; CORTICOTROPIN-RELEASING FACTOR RECEPTOR (CRF 1?) SPECIFIC LIGANDS
03/20/2002EP0957906B1 Local anesthetic for external use
03/20/2002EP0948340B1 Biologically active substances, method for obtaining and compositions containing them
03/20/2002EP0944590B1 Aminoguanidines and alkoxyguanidines as protease inhibitors
03/20/2002EP0944587B1 Metalloproteinase inhibitors
03/20/2002EP0942913A4 Ethylenediaminetriacetic acid and n-acyl ethylenediaminetriacetic acid silver chelactants
03/20/2002EP0937037B1 Sodium salt of [poly-(2,5-dihydroxyphenylene)]-4-thiosulphuric acid of linear structure as regulator of cell metabolism and production method thereof
03/20/2002EP0888356B1 Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
03/20/2002EP0871446B1 Use of eliprodil for the manufacture of a medicament for the treatment of ischemic disorders of the retina or the optic nerve
03/20/2002EP0837860B1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO(3,4-c]-1,2,4-TRIAZOLO(4,3-ALPHA]PYRIDINES
03/20/2002EP0830129B1 Solid compositions containing polyethyleneoxide and a non-amorphous active principle
03/20/2002EP0800829B1 Antitumor agent potentiator comprising il-6 antagonist
03/20/2002EP0786986B1 Use of an unsaturated fatty alcohol
03/20/2002EP0731078B1 Terpene-quinone with antitumor activity
03/20/2002EP0730458B1 Use of aldosterone antagonists to inhibit myocardial fibrosis
03/20/2002EP0604641B1 Use of a combination containing an amine or amine-related derivative of benzoic acid and an amino-polysaccharide in the manufacture of a medicament for the treatment of inflammatory diseases
03/20/2002EP0591385B1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
03/20/2002CN1341213A Process for screening compound having affinity for vitamin D receptor
03/20/2002CN1341124A Anti-CD3 immunotoxins and therapeutic use thereof
03/20/2002CN1341116A Crystal modification D of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-[4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
03/20/2002CN1341115A 16-halogen-epothilone derivatives, process for producing them and their pharmaceutical use
03/20/2002CN1341114A C-21 Modified epothilones
03/20/2002CN1341111A 1-phenyl-4-(1-[2-aryl]cyclopropyl) methylpiperazines: dopamine receptor ligands
03/20/2002CN1341104A 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
03/20/2002CN1341103A Pyridazin-3-one derivatives and medicines containing the same
03/20/2002CN1341102A Dopamine D1 receptor agonist compounds
03/20/2002CN1341101A Phenyl-and pyridinyl derivatives
03/20/2002CN1341100A 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists
03/20/2002CN1341099A 2-aminopyridines containing fused ring substituents
03/20/2002CN1341098A W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
03/20/2002CN1341095A Amide compounds for potentiation of cholinergic activity
03/20/2002CN1341094A Monoamine reuptake inhibitors for treatment of CNS disorders
03/20/2002CN1341029A Use of an OmpA enterobacteriumprotein associated with the ELAGIGILTV peptide for treating melanomas
03/20/2002CN1341025A Drugs containing sulfopyranosylacylglycerol derivatives
03/20/2002CN1341024A Methods of treamtment of mitochondrial disorders
03/20/2002CN1341023A Agent for use in transplantation
03/20/2002CN1341022A Pharmaceutical composition containing porton pump inhibitors
03/20/2002CN1341021A Use of polycyclic thiazole systems for producing medicaments for preventing of treating obesity
03/20/2002CN1341019A Antitumour synergistic composition
03/20/2002CN1341018A Gabapentin derivative for preventing and treating visceral pain
03/20/2002CN1341017A Combinations of formoterol and mometasone furoate for sathma
03/20/2002CN1341016A Effervescent laxatives
03/20/2002CN1341014A Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
03/20/2002CN1341013A Method of preparing particles for agglomeration
03/20/2002CN1340352A Quick-acting powdered medicine for treating stomatopathy
1 ... 5870 5871 5872 5873 5874 5875 5876 5877 5878 5879 5880 5881 5882 5883 5884 5885 5886 5887 5888 5889 5890 ... 7860